Opinion and Editorial

Activists protest inside a conference venue holding signs calling for cheaper access to lenacapavir and an end to drug patents.

Op-ed: SA government’s delay in Intellectual Property reform 12 years after dangerous ‘PharmaGate’ plot

To protect people’s right to healthcare, the South African government must table and pass the Patent Amendment Bill without delay It has been more than twelve years since the reveal of “PharmaGate,” a R6 million lobbying plot by the pharmaceutical…

Read More » Op-ed: SA government’s delay in Intellectual Property reform 12 years after dangerous ‘PharmaGate’ plot
HIV prevention

We are managing HIV with selective lenacapavir roll-out, not ending it

Lenacapavir promised to change the course of the epidemic, but a limited, geographically selective rollout exposes a harder reality: who gets protected, who is left behind, and whether this is progress or containment. What is presented as pragmatism is, in fact, a set of political choices about access, timing, and scale

Read More » We are managing HIV with selective lenacapavir roll-out, not ending it

Newsletter Subscription

Be in the know with our free weekly newsletter. We deliver a round-up of our top stories and insightful reads from across the web.

  • This field is for validation purposes and should be left unchanged.
Enable Notifications OK No thanks